Abstract:Ethnopharmacological relevance: Baicalein (B), a bioactive flavone isolated from the root of a traditional Chinese medicinal herb Scutellaria baicalensis Georgi, was found to undergo extensive intestinal Phase II metabolism during its absorption process. Compounds sharing the same metabolic pathways with B or being inhibitors of enzymes UGT and SULT are expected to interfere with the metabolism of B leading to alteration of the absorption of B. The present study aims to identify potential intestinal absorption and metabolism interactions between B and four selected compounds, namely acetaminophen (APAP), (-)-epicatechin (EC), piperine (PIP) and curcumin (CUR) using in vitro and in situ models.Materials and methods: Three in vitro and one in situ methods were employed to investigate the effect of selected compounds on the metabolism and absorption on B. Incubation studies using rat intestinal s9 and Caco-2 cell lysate were used to study the effect of selected compounds on glucuronidation and sulfation of B. Sigmoidal dose-response curves were plotted and IC50 values were estimated. Apical to basolateral absorption study using Caco-2 cell monolayer model was also employed to study the effect of selected compounds on absorption of B. The most potent inhibitor identified was selected to further investigate its potential herb-drug interaction with B using in situ rat intestinal perfusion model. LC/MS/MS was used for the analysis of B and its metabolites in collected samples.Results: It was found that all the four selected compounds could produce a dose-dependent inhibition on the glucuronidation and sulfation of B. Moreover, the presence of CUR and high-dose EC demonstrated a subsequent increase in the absorption of B. In general, the order of potency on glucuronidation inhibition is: CUR > PIP > EC > APAP; while the potency order on sulfation inhibition is: CUR > EC > PIP > APAP. CUR was selected to further study its in vivo effect on B using in situ rat intestinal perfusion model. It was found that CUR could significantly increase the absorption of B via the inhibition on formation of its metabolites.Conclusions: Our findings indicated that the intestinal metabolism of B could be inhibited by all the selected compounds with CUR being the most potent inhibitor, which could result in subsequent increase of absorption of B. The current study had significant implications for further investigation on the in vivo evaluations of the herb-drug and herb-herb interactions between B and selected compounds, especially CUR. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Construction on the Chitosan Microparticles of Baicalin and Comparison of Transdermal Diffusion in Vitro of Baicalin in Chitosan Microparticles and Cream

Characterization of Transformation Pattern of Baicalin Using UV Spectrometric Analysis and Multivariate Curve Resolution

Effect of Low Molecular Weight Chitosans on Drug Permeation Through Mouse Skin: 1. Transdermal Delivery of Baicalin.

Characterization and Evaluation in Vivo of Baicalin-Nanocrystals Prepared by an Ultrasonic-Homogenization-fluid Bed Drying Method

Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes

Study on Encapsulation Efficiency and in Vitro Release of Baicalin Liposomes

[Preparation of Baicalin-Chitooligosaccharide Compound and Its Characterization].

Effects of Baicalin Cream in Two Mouse Models: 2,4-Dinitrofluorobenzene-induced Contact Hypersensitivity and Mouse Tail Test for Psoriasis.

Preparation of Baicalin Cataplasma

In Vitroandin Vivostudy of Baicalin-loaded Mixed Micelles for Oral Delivery

Preparation of Baicalin Solid Dispersions and Investigation of Its Dissolution Behavior

In Vitro and in Situ Evaluation of Herb–drug Interactions During Intestinal Metabolism and Absorption of Baicalein

Pharmacokinetics and Bioavailability Enhancement of Baicalin: A Review

Nanostructured Lipid Carriers for Oral Delivery of Baicalin: in Vitro and in Vivo Evaluation

Preparation, characterisation and in vitro anti-inflammatory activity of Baicalin microsponges

Bioequivalence Study of Baicalin Capsules in Healthy Volunteers

Inhibition of skin inflammation by baicalin ultradeformable vesicles

Dissolution and pharmacokinetics of baicalin-polyvinylpyrrolidone coprecipitate.

Effect of enhancers on the baicalin transdermal therapeutic system

Study on the Solid Dispersion of Baicalin-Pvp_(k30)